Published in Nat Med on April 01, 1997
Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol (1998) 2.82
Tuberculous meningitis. J Neurol Neurosurg Psychiatry (2000) 2.05
Modern laboratory diagnosis of mycobacterial infections. J Clin Pathol (2000) 1.56
Cluster K mycobacteriophages: insights into the evolutionary origins of mycobacteriophage TM4. PLoS One (2011) 1.54
Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis. PLoS One (2009) 1.30
Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.29
Molecular Genetics of Mycobacteriophages. Microbiol Spectr (2014) 1.26
Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.25
Next-generation antimicrobial susceptibility testing. J Clin Microbiol (2013) 1.21
Rapid clinical bacteriology and its future impact. Ann Lab Med (2012) 1.16
Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol (1999) 1.16
Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (2003) 1.16
Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol (2004) 1.15
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob (2007) 1.06
Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. J Clin Microbiol (2006) 0.99
Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J Clin Microbiol (2003) 0.98
Phage-based platforms for the clinical detection of human bacterial pathogens. Bacteriophage (2012) 0.98
In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings. Antimicrob Agents Chemother (2005) 0.97
Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis. J Clin Microbiol (2003) 0.96
Application of bacteriophages for detection of foodborne pathogens. Bacteriophage (2014) 0.95
Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev (2014) 0.93
Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob (2006) 0.89
New biomolecular assays must be tested by direct study in the developing world. BMJ (1998) 0.83
Comparison of the performances of two in-house rapid methods for antitubercular drug susceptibility testing. Antimicrob Agents Chemother (2008) 0.82
A multi-center study to evaluate the performance of phage amplified biologically assay for detecting TB in sputum in the pulmonary TB patients. PLoS One (2011) 0.78
Colorimetric phage-based assay for detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol (2007) 0.78
Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin. Front Microbiol (2016) 0.75
Rapid screening of inhibitors of Mycobacterium tuberculosis growth using tetrazolium salts. Methods Mol Biol (2009) 0.75
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates. Indian J Med Res (2012) 0.75
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol (1993) 4.42
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Tuberculosis and HIV infection. Lancet (1993) 2.75
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet (2000) 2.74
Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A (1982) 2.29
Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis. J Infect Dis (1994) 2.21
Reproducible high yield of rat islets by stationary in vitro digestion following pancreatic ductal or portal venous collagenase injection. Transplantation (1987) 2.14
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax (2005) 2.09
Tuberculous meningitis. J Neurol Neurosurg Psychiatry (2000) 2.05
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Thiacetazone--avoid like poison or use with care? Trans R Soc Trop Med Hyg (1994) 1.88
AIDS and hepatitis B in the former Soviet Union. BMJ (1992) 1.65
Managing tuberculosis and HIV infection. BMJ (1992) 1.56
Evaluation of strategies for molecular fingerprinting for use in the routine work of a Mycobacterium reference unit. J Clin Microbiol (1998) 1.55
Drug-related deaths among medical inpatients. JAMA (1977) 1.53
Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis (2003) 1.52
Randomized comparison of routine vs highly selective use of Doppler ultrasound and biophysical scoring to investigate high risk pregnancies. Br J Obstet Gynaecol (1990) 1.52
Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis (2001) 1.52
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI) J Rheumatol (1995) 1.49
Relative analgesia. An evaluation of the efficacy and safety. Br Dent J (1979) 1.48
An improved colorimetric PCR-based method for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces. J Clin Microbiol (1997) 1.47
Increased risk of tuberculosis among health care workers in Samara Oblast, Russia: analysis of notification data. Int J Tuberc Lung Dis (2005) 1.46
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1978) 1.45
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. BMJ (1990) 1.45
Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol (2002) 1.44
Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med (1990) 1.44
The use of interferon-gamma-based blood tests for the detection of latent tuberculosis infection. Eur Respir J (2006) 1.42
Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis (2000) 1.42
Practice guidelines: lower extremity revascularization. J Vasc Surg (1993) 1.41
Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats. Antimicrob Agents Chemother (1991) 1.39
Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci U S A (1992) 1.38
Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet (1977) 1.33
India's Revised National Tuberculosis Control Programme: looking beyond detection and cure. Int J Tuberc Lung Dis (2008) 1.24
Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study. BMJ (2005) 1.24
Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ (2005) 1.22
Prognostic indicators in venous ulcers. J Am Acad Dermatol (2000) 1.22
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis (2005) 1.21
Health service providers' perceptions of barriers to tuberculosis care in Russia. Health Policy Plan (2006) 1.20
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ (1999) 1.19
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res (2006) 1.19
Stigma and HIV infection in Russia. AIDS Care (2006) 1.18
Visual benefit of correcting higher order aberrations of the eye. J Refract Surg (2001) 1.18
Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis (2008) 1.16
New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J Med Chem (1986) 1.15
Phosphorylase b kinase inheritance in mice. Science (1967) 1.14
Interferon-gamma and interleukin-2 release by lymphocytes derived from the blood, mesenteric lymph nodes and intestines of normal sheep and those affected with paratuberculosis (Johne's disease). Vet Immunol Immunopathol (1999) 1.13
Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res (1992) 1.13
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol (2000) 1.13
A study of immunological responses of sheep clinically-affected with paratuberculosis (Johne's disease). The relationship of blood, mesenteric lymph node and intestinal lymphocyte responses to gross and microscopic pathology. Vet Immunol Immunopathol (1998) 1.12
Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem (1999) 1.11
Enzyme-linked immunosorbent assay of ochratoxin A in barley. J Assoc Off Anal Chem (1983) 1.10
Crack users' cracked lips: an additional HIV risk factor. Am J Public Health (1993) 1.09
Molecular epidemiology of tuberculosis in England, 1998. Int J Tuberc Lung Dis (2009) 1.09
Direct measurements of natural planktonic bacterial community viability by flow cytometry. Appl Environ Microbiol (1995) 1.09
An incremental cost-effectiveness analysis of the first, second and third sputum examination in the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.08
HIV surveillance: the value of audit. BMJ (1991) 1.08
Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions. Eur J Public Health (2005) 1.07
Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J (2009) 1.07
Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol (2004) 1.07
Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review. Int J Tuberc Lung Dis (2012) 1.06
Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. Int J Tuberc Lung Dis (2003) 1.06
Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. Int J Tuberc Lung Dis (2012) 1.05
A novel post-translational modification involving bromination of tryptophan. Identification of the residue, L-6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom. J Biol Chem (1997) 1.05
Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol (2000) 1.04
The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem (1994) 1.04
Guidelines for establishing trials of new tests to diagnose tuberculosis in endemic countries. Int J Tuberc Lung Dis (2004) 1.03
Immunological characteristics of purified pancreatic islet grafts. Transplantation (1986) 1.03
Dominant-negative mutants of a platelet-derived growth factor gene. Genes Dev (1990) 1.03
The molecular epidemiology of tuberculosis in inner London. Epidemiol Infect (2002) 1.03
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example. Eur J Public Health (2004) 1.02
Performance of the GenoType® MTBDRPlus assay in routine settings: a multicenter study. Eur J Clin Microbiol Infect Dis (2011) 1.01
Impact of HIV infection on Zambian businesses. BMJ (1994) 1.01
Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum (1989) 1.01
Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. Am J Public Health (1997) 0.99
Can accident and emergency nurse practitioners interpret radiographs? A multicentre study. J Accid Emerg Med (1998) 0.99
Clinical importance of the interaction of phenytoin and isoniazid: a report from the Boston Collaborative Drug Surveillance Program. Chest (1979) 0.99
Gonadotropin-releasing hormone antagonists: novel members of the azaline B family. J Med Chem (1995) 0.99
Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings. J Clin Microbiol (2011) 0.99
Tuberculosis and HIV seroprevalence in Lambeth, Southwark and Lewisham, an area of South London. Respir Med (2003) 0.98
Survival and filamentation of Salmonella enterica serovar enteritidis PT4 and Salmonella enterica serovar typhimurium DT104 at low water activity. Appl Environ Microbiol (2000) 0.98
Multidrug resistance emerging in North London outbreak. Thorax (2006) 0.98
Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. AIDS (1997) 0.96
Identification of alkylidene hydrazides as glucagon receptor antagonists. J Med Chem (2001) 0.96
Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96
Response to cosmetic disfigurement: patients with vitiligo. Cutis (1987) 0.96
Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut (1997) 0.95
Human microsporidiosis in African AIDS patients with chronic diarrhea. J Infect Dis (1995) 0.95
Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis (2002) 0.95
Epidemic alert: malaria infections in travellers from West Africa. Lancet (1990) 0.95
Shifting the paradigm in tuberculosis control: illustrations from India. Int J Tuberc Lung Dis (1999) 0.94
Multiple drug resistant tuberculosis: aetiology, diagnosis and outcome. Br Med Bull (1998) 0.94
Effect of octreotide on fluid absorption and secretion by the normal human jejunum and ileum in vivo. Aliment Pharmacol Ther (2002) 0.94